SAN JOSE, Calif. — Loop Genomics has come one step closer to replacing Sanger sequencing with NGS. Loop’s new product enables massively parallel multiplexing of colonies and cloned DNA’s into a single tube and sequencing them on NGS instruments, reducing the time and cost of sequencing cloned DNA. “The decades old practice of sequencing amplicons from colonies is still prohibitively […]
Manchester, UK: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group, today announces a proposed placing (the “Placing”) of new ordinary shares of 0.1 pence each (“Ordinary Shares”) in the capital of the Company (the “Placing Shares”) at a price of 17 pence per share (the “Placing Price”) to raise a minimum of £13 million. The […]
CRISPR-based screening technology platform to address critical gaps in target ID and validation Single cell RNAseq-linked pooled CRISPR screening offers high-quality screening data and biological insight Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company”, or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-launch introduction of its new HTG EdgeSeq Reveal RUO oncology applications, which are expected to be commercially available globally in late August with the release of HTG EdgeSeq Reveal version 3.0. […]
ANN ARBOR, Mich. — Swift Biosciences, a leader in Next-Generation Sequencing Technology lays the groundwork for emerging research into common and rare disease as well as novel infectious disease. The Company’s Accel-Amplicon® and Swift Normalase® Amplicon Panels (SNAP) use a patented single tube workflow, to create ready to sequence libraries for research in Cancer, Antibiotic […]
DURHAM, N.C. — BioSkryb, Inc. (“BioSkryb”), a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced that it has launched an Early Access Program (EAP) for researchers to test its proprietary genomic amplification technology (Primary Template-directed Amplification or PTA). Enrollment in the program secures dedicated workflow support to ensure […]
Joint research effort will lead to molecular assays that can improve variant detection and access difficult-to-sequence regions of the human genomeAUSTIN, Texas and MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, and Asuragen, a molecular diagnostics company delivering easy-to-use products for complex […]
Cancer Transcriptome Atlas is the First in a Portfolio of GeoMx Products That Enable Spatial Genomics Using the Installed Base of Nearly 20,000 Next Gen Sequencers SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the first GeoMx® Digital Spatial […]
Ground-breaking British technology will initially provide hundreds of thousands of fast, accurate, low-cost COVID-19 tests under new agreement with the UK Government, with the potential to build to millions of tests per month The “LamPORE COVID-19” assay provides precise detection of SARS-CoV-2, the virus that causes COVID-19, using Oxford Nanopore’s DNA/RNA sequencing technology. LamPORE is […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced execution of a letter contract with the National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering, for a proposed project under the agency’s Rapid Acceleration of Diagnostics (RADx) […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
